Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.51 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | HTR2B | P41595 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.42 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.42 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.42 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.42 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29484444 | 1.00 | HTR2A (0.51) | HTR2AHTR2CHTR2BALDH1A1CYP1A2 | |
| SCHEMBL28422249 | 1.00 | HTR2A (0.51) | HTR2AHTR2CHTR2BALDH1A1CYP1A2 | |
| SCHEMBL28893602 | 1.00 | HTR2A (0.51) | HTR2AHTR2CHTR2BALDH1A1CYP1A2 | |
| Ammonia Solution, Strong SCHEMBL1780462 | 0.98 | HTR2A (0.50) | HTR2AHTR2CHTR2BALDH1A1CYP1A2 | |
| SCHEMBL6014505 | 0.85 | ALDH1A1 (0.47) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL28381940 | 0.84 | ALDH1A1 (0.43) | HTR2AHTR2CHTR2BALDH1A1CYP1A2 | |
| SCHEMBL6307997 | 0.82 | HTR1B (0.45) | HTR2AALDH1A1CYP1A2CYP2C9CYP2C19 | |
| SCHEMBL2127427 | 0.82 | TSHR (0.55) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL15211048 | 0.82 | TSHR (0.55) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 | |
| SCHEMBL3412393 | 0.80 | CYP1A2 (0.50) | ALDH1A1CYP1A2CYP2C9CYP2C19AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111916571-A | Red perovskite light emitting diode based on mixed halogen and preparation method thereof | 华南理工大学 | 2020-11-10 | — | — | CN | claimed |
| JP-59007146-A | — | — | None | — | — | JP | disclosed |
| CN-112494644-B | Composite adjuvant, vaccine containing composite adjuvant and application | 中国医学科学院医学生物学研究所 | 2024-02-06 | — | — | CN | disclosed |
| CN-111916571-B | Red perovskite light emitting diode based on mixed halogen and preparation method thereof | 华南理工大学 | 2022-03-29 | — | — | CN | disclosed |
| CN-112494644-A | Compound adjuvant, vaccine containing compound adjuvant and application | 中国医学科学院医学生物学研究所 | 2021-03-16 | — | — | CN | disclosed |
| CN-111916571-A | Red perovskite light emitting diode based on mixed halogen and preparation method thereof | 华南理工大学 | 2020-11-10 | — | — | CN | disclosed |
| US-7098215-B2 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 2006-08-29 | — | — | US | disclosed |
| US-6869950-B1 | Benzimidazole derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2005-03-22 | — | — | US | disclosed |
| US-20040157818-A1 | Cxcr4-antagonistic drugs composed of nitrogen-containing compound | KUREHA CORPORATION (JP) | 2004-08-12 | — | — | US | disclosed |
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | KUREHA CORPORATION (JP) | 2004-05-13 | — | — | US | disclosed |
| EP-1389460-A1 | CXCR4-ANTAGONISTIC DRUGS COMPRISING NITROGEN-CONTAINING COMPOUND | Kureha Chemical Industry Co., Ltd. (JP) | 2004-02-18 | — | — | EP | disclosed |
| EP-1273571-A1 | NITROGENOUS COMPOUNDS AND ANTIVIRAL DRUGS CONTAINING THE SAME | Kureha Chemical Industry Co., Ltd. (JP) | 2003-01-08 | — | — | EP | disclosed |
| EP-1142880-A1 | BENZIMIDAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-10-10 | — | — | EP | disclosed |
| EP-0335641-B1 | Organic nonlinear optical substance | TEIJIN LTD (JP) | 1994-01-05 | — | — | EP | disclosed |
| US-5196147-A | Optical crystals | TEIJIN LIMITED (JP) | 1993-03-23 | — | — | US | disclosed |
| US-4987132-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| EP-0335641-A2 | Organic nonlinear optical substance | TEIJIN LIMITED (JP) | 1989-10-04 | — | — | EP | disclosed |
| JP-S597146-A | N-(1-BETA-NAPHTHYL-ISOPROPYL)PHENYLACETAMIDE DERIVATIVE, ITS PREPARATION AND HERBICIDE CONTAINING THE SAME | IDEMITSU KOSAN CO LTD | 1984-01-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040092556-A1 | Nitrogenous compounds and antiviral drugs containing the same | NSUN2, ZC3HAV1L, PNP | HTR2A 3798/4885HTR2C 2709/4885HTR2B 3581/4885 |
| US-20040157818-A1 | Cxcr4-antagonistic drugs composed of nitrogen-containing compound | CXCR4, CXCR1, CXCR2 | HTR2A 1593/4885HTR2C 1876/4885HTR2B 1834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.